Smith, R.T.; Dahlgren, M.K.; Sagar, K.A.; Kosereisoglu, D.; Gruber, S.A.
Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study. Biomedicines 2025, 13, 1874.
https://doi.org/10.3390/biomedicines13081874
AMA Style
Smith RT, Dahlgren MK, Sagar KA, Kosereisoglu D, Gruber SA.
Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study. Biomedicines. 2025; 13(8):1874.
https://doi.org/10.3390/biomedicines13081874
Chicago/Turabian Style
Smith, Rosemary T., Mary Kathryn Dahlgren, Kelly A. Sagar, Deniz Kosereisoglu, and Staci A. Gruber.
2025. "Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study" Biomedicines 13, no. 8: 1874.
https://doi.org/10.3390/biomedicines13081874
APA Style
Smith, R. T., Dahlgren, M. K., Sagar, K. A., Kosereisoglu, D., & Gruber, S. A.
(2025). Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study. Biomedicines, 13(8), 1874.
https://doi.org/10.3390/biomedicines13081874
